Study title:
Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging : Frühwald MC, Rickert CH, O'Dorisio MS, Madsen M, Warmuth-Metz M, Khanna G, Paulus W, Kühl J, Jürgens H, Schneider P, Müller HL; Clin Cancer Res. 2004 May 1;10(9):2997-3006
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis [E01]
|
Brands: Please see report, Please see report, Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: (111In) INDIUM CHLORIDE/PENTETREOTIDE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|